Aprea Therapeutics, Inc. (APRE)

Investing Cash Flow

-$15.75K

TTM · Period ending: · USD

APRE logo

APRE Investing Cash Flow

Latest reported-$15.75K
APRE TTM Cash from Investing (-$30.77K → -$15.75K)
High-resolution chart · PNG

APRE investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aprea Therapeutics, Inc. Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-15,748
0
0
0
0
-7,500
-15,478
-22,628
-108,571
-101,071
-93,093
-85,943
0
0
0
0
0
0
0
-16,290
-16,135
-14,114
-26,279
-24,322
-34,723
-42,933
-30,768
-15,631
-5,157
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.